1
|
Kalayci Onac A, Cetin M, Sevik H, Orman P, Karci A, Gonullu Sutcuoglu G. Rethinking the campus transportation network in the scope of ecological design principles: case study of Izmir Katip Çelebi University Çiğli Campus. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2021; 28:50847-50866. [PMID: 33973118 DOI: 10.1007/s11356-021-14299-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Accepted: 05/03/2021] [Indexed: 06/12/2023]
Abstract
The concept of sustainability, which has become increasingly important in every aspect of life, has become a topic that is often emphasized for university campuses, which can be considered a small urban model. Many universities in Turkey and abroad are working on sustainable campuses. They set many environmental, social, and economic targets such as reducing the carbon footprint, using green technologies, designing by human and environment oriented principles, using green transportation systems, reducing costs, and eliminating social injustice. In this study, the transportation network of İzmir Katip Çelebi University, Çiğli Campus, which was established on an area of 70 ha in 2010, was examined within the scope of sustainability and ecological design criteria, and a transportation network focused on pedestrian and bicycle was also suggested. This study consists of two stages. In the first stage, the current situation analysis of the campus transportation was presented, and in the second stage, recommendations were made for a sustainable transportation system within the campus, taking into account the ecological design criteria.
Collapse
Affiliation(s)
- Ayse Kalayci Onac
- Faculty of Engineering and Architecture, Department of City and Regional Planning, Izmir Katip Celebi University, Izmir, Turkey
| | - Mehmet Cetin
- Faculty of Engineering and Architecture, Department of Landscape Architecture, Kastamonu University, Kastamonu, Turkey.
| | - Hakan Sevik
- Faculty of Engineering and Architecture, Department of Environmental Engineering, Kastamonu University, Kastamonu, Turkey
| | - Pinar Orman
- Faculty of Engineering and Architecture, Department of Architecture, Izmir Katip Celebi University, Izmir, Turkey
| | - Ahenk Karci
- Graduate School of Natural and Applied Sciences, Department of Urban Regeneration, Izmir Katip Celebi University, Izmir, Turkey
| | - Gokce Gonullu Sutcuoglu
- Graduate School of Natural and Applied Sciences, Department of Urban Regeneration, Izmir Katip Celebi University, Izmir, Turkey
| |
Collapse
|
2
|
Shafiq N, Shafiq S, Rafiq N, Parveen S, Javed I, Majeed HN, Mahmood A, Noor N, Anjum A. Review: Phytochemicals of the Seriphidium, Economically and Pharmaceutically Important Genus of Asteraceae Family. MINI-REV ORG CHEM 2020. [DOI: 10.2174/1570193x16666190319153647] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Seriphidium plants were reported to be utilized by local communities to cure their ailments
in the form of paste, tincture, tea, nutraceuticals due to their medicinal properties. Most of the species
are used as food, forage and ornamentals, etc. Due to the significant properties of the Seriphidium
plants, the present article was designed to compile the data of major aspects and chemical constituents
of genus Seriphidium responsible for their significant uses. This review article comprehensively
covers the biological potential of different plants with their secondary metabolites and describes an
overview of the biological activities of the different species belonging to genus Seriphidium. The
main secondary metabolites isolated from different species of the genus Seriphidium are triterpenoid,
sesquiterpenes, flavonoids, coumarins, chromones, anthraquinones, polyphenols and their glycosides,
phenolic derivatives, balchanins, costunolides, Vulgarin, pyridine derivatives, ceramides, biphenyls,
isoflavones. All these compounds are used in the drug industry.
Collapse
Affiliation(s)
- Nusrat Shafiq
- Department of Chemistry, Faculty of Sciences & Technology, Government College Women University, Faisalabad- 38000, Pakistan
| | - Sahrish Shafiq
- Department of Chemistry, Faculty of Sciences & Technology, Government College Women University, Faisalabad- 38000, Pakistan
| | - Naila Rafiq
- Department of Bio-Chemistry, Government College Women University, Faisalabad-38000, Pakistan
| | - Shagufta Parveen
- Department of Chemistry, Faculty of Sciences & Technology, Government College Women University, Faisalabad- 38000, Pakistan
| | - Irum Javed
- Department of Bio-Chemistry, Government College Women University, Faisalabad-38000, Pakistan
| | - Humara Naz Majeed
- Department of Bio-Chemistry, Government College Women University, Faisalabad-38000, Pakistan
| | - Ayesha Mahmood
- Department of Chemistry, Faculty of Sciences & Technology, Government College Women University, Faisalabad- 38000, Pakistan
| | - Nadia Noor
- Department of Chemistry, Faculty of Sciences & Technology, Government College Women University, Faisalabad- 38000, Pakistan
| | - Abrar Anjum
- Department of Basic Sciences, UET, Taxila College, Taxilla Cantt. 47050, Pakistan
| |
Collapse
|
3
|
Thummala Y, Karunakar GV, Doddi VR. DBU‐Mediated Synthesis of Aryl Acetylenes or 1‐Bromoethynylarenes from Aldehydes. Adv Synth Catal 2018. [DOI: 10.1002/adsc.201801334] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Yadagiri Thummala
- Academy of Scientific and Innovative Research (AcSIR)CSIR-Indian Institute of Chemical Technology (CSIR-IICT) Hyderabad 500007 India
| | - Galla V. Karunakar
- Academy of Scientific and Innovative Research (AcSIR)CSIR-Indian Institute of Chemical Technology (CSIR-IICT) Hyderabad 500007 India
| | - Venkata Ramana Doddi
- Academy of Scientific and Innovative Research (AcSIR)CSIR-Indian Institute of Chemical Technology (CSIR-IICT) Hyderabad 500007 India
- Department of Chemistry and Chemical SciencesCentral University of Jammu Jammu India
| |
Collapse
|
4
|
Salehi P, Shiri M. Palladium‐Catalyzed Regioselective Synthesis of 3‐(Hetero)Arylpropynamides from
gem
‐Dibromoalkenes and Isocyanides. Adv Synth Catal 2018. [DOI: 10.1002/adsc.201800963] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Parvin Salehi
- Department of ChemistryAlzahra University, Vanak Tehran 1993893973 Iran
| | - Morteza Shiri
- Department of ChemistryAlzahra University, Vanak Tehran 1993893973 Iran
| |
Collapse
|
5
|
Ramasamy S, Petha C, Tendulkar S, Maity P, Eastgate MD, Vaidyanathan R. Synergistic Effect of Copper and Ruthenium on Regioselectivity in the Alkyne–Azide Click Reaction of Internal Alkynes. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00163] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Sivaraj Ramasamy
- Chemical Development and API Supply, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India
| | - Chittibabu Petha
- Chemical Development and API Supply, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India
| | - Shankar Tendulkar
- Chemical Development and API Supply, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India
| | - Prantik Maity
- Chemical Development and API Supply, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India
| | - Martin D. Eastgate
- Chemical and Synthetic Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
| | - Rajappa Vaidyanathan
- Chemical Development and API Supply, Biocon Bristol-Myers Squibb Research and Development Center, Biocon Park, Jigani Link Road, Bommasandra IV, Bangalore 560099, India
| |
Collapse
|
6
|
Krishna Moodapelly S, Sharma GVM, Ramana Doddi V. Controlled Reactivity of 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) in the Selective Synthesis of 1-(Bromoethynyl)arenes. Adv Synth Catal 2017. [DOI: 10.1002/adsc.201601279] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Shiva Krishna Moodapelly
- Organic and Biomolecular Chemistry Division; CSIR-Indian Institute of Chemical Technology (CSIR-IICT); Hyderabad - 500007 India
| | - Gangavaram V. M. Sharma
- Organic and Biomolecular Chemistry Division; CSIR-Indian Institute of Chemical Technology (CSIR-IICT); Hyderabad - 500007 India
| | - Venkata Ramana Doddi
- Organic and Biomolecular Chemistry Division; CSIR-Indian Institute of Chemical Technology (CSIR-IICT); Hyderabad - 500007 India
- Department of Chemistry and Chemical Sciences; Central University of Jammu; Jammu India
| |
Collapse
|
7
|
Zhang P, Zou MF, Rodriguez AL, Conn PJ, Newman AH. Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5. Bioorg Med Chem 2010; 18:3026-35. [PMID: 20382541 DOI: 10.1016/j.bmc.2010.03.053] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2010] [Revised: 03/18/2010] [Accepted: 03/23/2010] [Indexed: 10/19/2022]
Abstract
The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in numerous neuropsychiatric disorders including addiction. We have discovered that the rigid diaryl alkyne template, derived from the potent and selective noncompetitive mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP), can serve to guide the design of novel quinoline analogues and pharmacophore optimization has resulted in potent mGluR5 noncompetitive antagonists (EC(50) range 60-100 nM) in the quinoline series.
Collapse
Affiliation(s)
- Peng Zhang
- Medicinal Chemistry Section, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD 21224, USA
| | | | | | | | | |
Collapse
|
8
|
Zhou Y, Rodriguez AL, Williams R, Weaver CD, Conn PJ, Lindsley CW. Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS. Bioorg Med Chem Lett 2009; 19:6502-6. [PMID: 19875287 DOI: 10.1016/j.bmcl.2009.10.059] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2009] [Revised: 10/12/2009] [Accepted: 10/14/2009] [Indexed: 11/28/2022]
Abstract
This Letter describes the discovery and SAR of three novel series of mGluR5 non-competitive antagonists/negative allosteric modulators (NAMs) not based on manipulation of an MPEP/MTEP chemotype identified by a functional HTS approach. This work demonstrates fundamentally new mGluR5 NAM chemotypes with submicromolar potencies, and further examples of a mode of pharmacology 'switch' to provide PAMs with a non-MPEP scaffold.
Collapse
Affiliation(s)
- Ya Zhou
- Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
| | | | | | | | | | | |
Collapse
|
9
|
Kulkarni SS, Zou MF, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH. Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists. J Med Chem 2009; 52:3563-75. [PMID: 19445453 DOI: 10.1021/jm900172f] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in anxiety, depression, pain, mental retardation, and addiction. The potent and selective noncompetitive mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP, 1) has been a critically important tool used to further elucidate the role of mGluR5 in these CNS disorders. In an effort to provide novel and structurally diverse selective mGluR5 antagonists, we previously described a set of analogues with moderate activity wherein the alkyne bond was replaced with an amide group. In the present report, extended series of both amide and alkyne-based ligands were synthesized. MGluR5 binding and functional data were obtained that identified (1) several novel alkynes with comparable affinities to 1 at mGluR5 (e.g., 10 and 20-23), but (2) most structural variations to the amide template were not well tolerated, although a few potent amides were discovered (e.g., 55 and 56). Several of these novel analogues show drug-like physical properties (e.g., cLogP range = 2-5) that support their use for in vivo investigation into the role of mGluR5 in CNS disorders.
Collapse
Affiliation(s)
- Santosh S Kulkarni
- Medicinal Chemistry Section, National Institute on Drug Abuse-Intramural Research Program, NIH, Baltimore, MD 21224, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Rodriguez AL, Williams R, Zhou Y, Lindsley SR, Le U, Grier MD, Weaver CD, Conn PJ, Lindsley CW. Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype. Bioorg Med Chem Lett 2009; 19:3209-13. [PMID: 19443219 DOI: 10.1016/j.bmcl.2009.04.110] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2009] [Revised: 04/22/2009] [Accepted: 04/23/2009] [Indexed: 11/29/2022]
Abstract
This Letter describes the discovery and SAR of three novel series of mGluR5 non-competitive antagonists/negative allosteric modulators (NAMs) not based on manipulation of an MPEP/MTEP chemotype. This work demonstrates fundamentally new mGluR5 NAM chemotypes with submicromolar potencies, and the first example of a mode of pharmacology 'switch' to provide PAMs with a non-MPEP scaffold.
Collapse
Affiliation(s)
- Alice L Rodriguez
- Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Carroll FI. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Ann N Y Acad Sci 2008; 1141:221-32. [PMID: 18991960 DOI: 10.1196/annals.1441.015] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
As a result of intensive investigation, particularly in the pharmaceutical industry, a number of potent and selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonists have been discovered. The structure activity relationship studies that led to the discovery of these mGluR5 antagonists are presented in this review. Results from studies on selected mGluR5 antagonists in animal models that simulate drug reward, reinforcement, and relapse appear promising. The comorbidity between drug abuse and anxiety and depression make drugs active in these disorders of great interest. Clinical studies showed that the mGluR5 antagonist fenobam was an active anxiolytic drug. Several new mGluR5 antagonists produced anxiolytic and antidepressant-like effects in animal models of these disorders. The results from the clinical and animal studies provide information for new approaches to finding mechanistically distinct pharmacotherapies to help patients achieve and maintain abstinence from cocaine, methamphetamine, opiates, ethanol, and nicotine (smoking).
Collapse
Affiliation(s)
- F Ivy Carroll
- Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, NC 27709-2194, USA.
| |
Collapse
|
12
|
Okutani M, Mori Y. Conversion of Bromoalkenes into Alkynes by Wet Tetra-n-butylammonium Fluoride. J Org Chem 2008; 74:442-4. [DOI: 10.1021/jo802101a] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Masaru Okutani
- Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan
| | - Yuji Mori
- Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan
| |
Collapse
|
13
|
Micheli F, Bertani B, Bozzoli A, Crippa L, Cavanni P, Di Fabio R, Donati D, Marzorati P, Merlo G, Paio A, Perugini L, Zarantonello P. Phenylethynyl-pyrrolo[1,2-a]pyrazine: A new potent and selective tool in the mGluR5 antagonists arena. Bioorg Med Chem Lett 2008; 18:1804-9. [PMID: 18304814 DOI: 10.1016/j.bmcl.2008.02.024] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2008] [Revised: 02/08/2008] [Accepted: 02/10/2008] [Indexed: 11/25/2022]
|
14
|
Jaeschke G, Wettstein JG, Nordquist RE, Spooren W. mGlu5 receptor antagonists and their therapeutic potential. Expert Opin Ther Pat 2008. [DOI: 10.1517/13543776.18.2.123] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
15
|
Fraser HL, Hopper DW, Kutterer KM, Crombie AL. Chapter 6.1 Six-membered ring systems: pyridine and benzo derivatives. ACTA ACUST UNITED AC 2008. [DOI: 10.1016/s0959-6380(08)80014-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
16
|
Galatsis P, Yamagata K, Wendt JA, Connolly CJ, Mickelson JW, Milbank JB, Bove SE, Knauer CS, Brooker RM, Augelli-Szafran CE, Schwarz RD, Kinsora JJ, Kilgore KS. Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett 2007; 17:6525-8. [DOI: 10.1016/j.bmcl.2007.09.083] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2007] [Revised: 09/24/2007] [Accepted: 09/25/2007] [Indexed: 10/22/2022]
|
17
|
Wendt JA, Deeter SD, Bove SE, Knauer CS, Brooker RM, Augelli-Szafran CE, Schwarz RD, Kinsora JJ, Kilgore KS. Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett 2007; 17:5396-9. [PMID: 17723296 DOI: 10.1016/j.bmcl.2007.07.047] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2007] [Revised: 07/18/2007] [Accepted: 07/19/2007] [Indexed: 10/23/2022]
Abstract
A novel series of potent 2-aryl pyrido[2,3-d]pyrimidine mGlu5 receptor antagonists are described. The synthesis and pharmacological activities of these analogs are discussed.
Collapse
Affiliation(s)
- John A Wendt
- Department of Medicinal Chemistry, Pfizer Global Research & Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Milbank JBJ, Knauer CS, Augelli-Szafran CE, Sakkab-Tan AT, Lin KK, Yamagata K, Hoffman JK, Zhuang N, Thomas J, Galatsis P, Wendt JA, Mickelson JW, Schwarz RD, Kinsora JJ, Lotarski SM, Stakich K, Gillespie KK, Lam WW, Mutlib AE. Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett 2007; 17:4415-8. [PMID: 17590335 DOI: 10.1016/j.bmcl.2007.06.030] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2007] [Revised: 06/04/2007] [Accepted: 06/05/2007] [Indexed: 11/16/2022]
Abstract
Rational replacement of the alkyne linker of mGluR5 antagonist MPEP gave 7-arylquinolines. SAR optimization gave an orally active compound with high affinity for the MPEP binding site.
Collapse
Affiliation(s)
- Jared B J Milbank
- Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Bach P, Isaac M, Slassi A. Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications. Expert Opin Ther Pat 2007. [DOI: 10.1517/13543776.17.4.371] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
|